NOVUS THERAPEUTICS INC's ticker is NVUS and the CUSIP is 67011N105. A total of 18 filers reported holding NOVUS THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 828,876 | $522,000 | 0.06% |
| 683 Capital Management, LLC | 623,102 | $386,000 | 0.04% |
| Orbimed Advisors | 3,183,314 | $1,974,000 | 0.04% |
| Boxer Capital, LLC | 324,383 | $201,000 | 0.02% |
| Hayden Royal, LLC | 10,000 | $6,000 | 0.01% |
| Virtu Financial LLC | 14,109 | $9,000 | 0.00% |
| VANGUARD GROUP INC | 62,761 | $39,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 2,110 | $1,000 | 0.00% |
| ROYAL BANK OF CANADA | 254 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |